Latest Cord blood Stories
Technique expands scarce resources used for cord blood transplant procedure A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient's body than with a conventional cord blood transplant procedure, according to new research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 53rd American...
SAN DIEGO, Dec. 10, 2011 /PRNewswire-USNewswire/ -- Hematopoietic cell transplantation (HCT), the transplantation of blood-forming stem cells from the bone marrow, peripheral blood, or umbilical cord blood, is the primary option for treatment for many patients who suffer from various hematologic disorders, including blood cancers, sickle cell disease, bone marrow deficiencies, bleeding disorders, and autoimmune disorders. Research investigating breakthroughs in hematopoietic cell...
These Quick Gifts Save Lives, and Don't Cost a Dime NEW YORK, Dec. 9, 2011 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, and New Jersey, is facilitating holiday gifts that allow people to donate life-saving blood in someone's honor - "free" gifts with meaning. "Think about all the people in your life who've been in a car accident, or had surgery, or are dealing with cancer. They...
LAS VEGAS, Dec. 8, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that co-founder and CEO Matthew Schissler was interviewed by analyst Francis Gaskins about the Company's 2011 financial performance. The entire interview is available at:...
HONG KONG, Nov. 18, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("the Company") today announced its plan to release financial results for the second quarter and first half of fiscal year 2012 on Monday, November 28, 2011, after market close in the US. The Company will host a conference call at 8:00 a.m. ET on Tuesday, November 29, 2011 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question...
GeneCell International, The First and Only Cord Blood, Dental Pulp and Adipose Stem Cell Processing Laboratory and Cryogenic Storage Facility in Miami opens a new laboratory at the facilities of prominent esthetics group, Pierini Estetic Surgery. Miami, Florida (PRWEB) November 17, 2011 GeneCell International specializes in the collection, transport, processing and cryogenic storage of adult stem cells from various sources including; umbilical cord blood, dental pulp and adipose (fat)...
Researchers have identified a potential marker for leukemic relapse The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse. The researchers' findings, published recently in Blood,...
LAS VEGAS, Nov. 17, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today is pleased to announce that it has been notified by The Depository Trust & Clearing Corp. that the "chill" announced by the DTCC in December 2010 has been removed. About Cord Blood America Cord Blood...
According to new research, waiting at least three minutes before clamping the umbilical cord of a newborn baby improves their iron levels at four months. The study said that delaying cord clamping is not linked to neonatal jaundice or other adverse health effects and should be standard care after uncomplicated pregnancies. Although other research indicates that delayed cord clamping could prevent iron deficiency, these studies had conflicting results regarding the risk of neonatal...
LAS VEGAS, Nov. 16, 2011 /PRNewswire/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that it has signed its fourth Supplier Agreement with a well-respected, accredited, tissue bank for which it will provide placenta collection services for research and transplantation use by the tissue bank. "This contract is...
